Form 4: Rhythm Pharmaceuticals Director Exercises Stock Options

Director Edward T. Mathers reports the exercise of stock options and vesting of restricted stock units in Rhythm Pharmaceuticals.

Summary

• On June 21, 2024, Edward T. Mathers, a director of Rhythm Pharmaceuticals, exercised stock options to acquire 3,000 shares of common stock.
• The transaction involved the vesting of 3,000 restricted stock units, each representing a contingent right to receive one share of Rhythm Pharmaceuticals common stock.
• Following the reported transaction, Mathers directly owns 3,000 shares of common stock.
• Mathers also indirectly owns 5,771 shares through the Edward Timothy Mathers Revocable Trust, but disclaims beneficial ownership of the portion in which he has no pecuniary interest.

Sentiment

Score: 5

Explanation: The document is a neutral regulatory filing detailing stock transactions by a company director. It doesn't inherently convey positive or negative sentiment.

Future Outlook

The document does not contain any forward-looking statements regarding the company's future performance.

Industry Context

This is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company directors.

Stakeholder Impact

• The transaction may have a minor impact on shareholders due to the increase in the number of outstanding shares.

Key Dates